rs181190356

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012186.3(FOXE3):​c.-14G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0361 in 1,320,086 control chromosomes in the GnomAD database, including 1,661 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 250 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1411 hom. )

Consequence

FOXE3
NM_012186.3 5_prime_UTR

Scores

1
1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.356

Publications

3 publications found
Variant links:
Genes affected
FOXE3 (HGNC:3808): (forkhead box E3) This intronless gene belongs to the forkhead family of transcription factors, which is characterized by a distinct forkhead domain. The protein encoded functions as a lens-specific transcription factor and plays an important role in vertebrate lens formation. Mutations in this gene are associated with anterior segment mesenchymal dysgenesis and congenital primary aphakia. [provided by RefSeq, Dec 2009]
LINC01389 (HGNC:50661): (long intergenic non-protein coding RNA 1389)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 1-47416302-G-A is Benign according to our data. Variant chr1-47416302-G-A is described in ClinVar as Benign. ClinVar VariationId is 260210.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.178 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012186.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FOXE3
NM_012186.3
MANE Select
c.-14G>A
5_prime_UTR
Exon 1 of 1NP_036318.1
LINC01389
NR_126355.1
n.29-6401C>T
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FOXE3
ENST00000335071.4
TSL:6 MANE Select
c.-14G>A
5_prime_UTR
Exon 1 of 1ENSP00000334472.2
LINC01389
ENST00000828805.1
n.207+17061C>T
intron
N/A
LINC01389
ENST00000828806.1
n.92+929C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0431
AC:
6499
AN:
150946
Hom.:
249
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0245
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0829
Gnomad ASJ
AF:
0.0266
Gnomad EAS
AF:
0.187
Gnomad SAS
AF:
0.135
Gnomad FIN
AF:
0.0562
Gnomad MID
AF:
0.0545
Gnomad NFE
AF:
0.0272
Gnomad OTH
AF:
0.0376
GnomAD2 exomes
AF:
0.0812
AC:
2894
AN:
35650
AF XY:
0.0845
show subpopulations
Gnomad AFR exome
AF:
0.0177
Gnomad AMR exome
AF:
0.115
Gnomad ASJ exome
AF:
0.0297
Gnomad EAS exome
AF:
0.248
Gnomad FIN exome
AF:
0.0566
Gnomad NFE exome
AF:
0.0335
Gnomad OTH exome
AF:
0.0600
GnomAD4 exome
AF:
0.0352
AC:
41110
AN:
1169036
Hom.:
1411
Cov.:
30
AF XY:
0.0367
AC XY:
20859
AN XY:
568874
show subpopulations
African (AFR)
AF:
0.0227
AC:
550
AN:
24274
American (AMR)
AF:
0.109
AC:
1855
AN:
16974
Ashkenazi Jewish (ASJ)
AF:
0.0264
AC:
455
AN:
17236
East Asian (EAS)
AF:
0.156
AC:
4064
AN:
26040
South Asian (SAS)
AF:
0.128
AC:
5890
AN:
45924
European-Finnish (FIN)
AF:
0.0489
AC:
1224
AN:
25046
Middle Eastern (MID)
AF:
0.0671
AC:
217
AN:
3232
European-Non Finnish (NFE)
AF:
0.0255
AC:
24530
AN:
963552
Other (OTH)
AF:
0.0497
AC:
2325
AN:
46758
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1665
3330
4994
6659
8324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1120
2240
3360
4480
5600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0431
AC:
6516
AN:
151050
Hom.:
250
Cov.:
32
AF XY:
0.0484
AC XY:
3571
AN XY:
73712
show subpopulations
African (AFR)
AF:
0.0244
AC:
1013
AN:
41436
American (AMR)
AF:
0.0833
AC:
1269
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.0266
AC:
91
AN:
3418
East Asian (EAS)
AF:
0.188
AC:
958
AN:
5094
South Asian (SAS)
AF:
0.135
AC:
652
AN:
4816
European-Finnish (FIN)
AF:
0.0562
AC:
592
AN:
10528
Middle Eastern (MID)
AF:
0.0517
AC:
15
AN:
290
European-Non Finnish (NFE)
AF:
0.0272
AC:
1830
AN:
67228
Other (OTH)
AF:
0.0429
AC:
90
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
312
624
935
1247
1559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00567
Hom.:
1
Bravo
AF:
0.0425
Asia WGS
AF:
0.185
AC:
631
AN:
3418

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 31, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: FOXE3 c.-14G>A alters a non-conserved nucleotide located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 0.081 in 35650 control chromosomes in the gnomAD database, including 189 homozygotes. The observed variant frequency exceeds the estimated maximal expected allele frequency for a pathogenic variant in FOXE3 causing Aortic Aneurysm, Familial Thoracic 11 phenotype (6.3e-07), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.-14G>A in individuals affected with Aortic Aneurysm, Familial Thoracic 11 and no experimental evidence demonstrating its impact on protein function have been reported. Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign.

Jan 11, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Jun 17, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29461140)

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
14
DANN
Uncertain
0.98
PhyloP100
0.36
PromoterAI
0.25
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181190356; hg19: chr1-47881974; API